ANSTO provides groundwork for promising new nuclear medicine
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
Showing 781 - 800 of 847 results
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
High intensity X-ray beam provides insights into the activity of natural killer cells.
Modelling and experimentation - a powerful combination in probing mechanical properties of ion irradiated materials through nanoindentation.
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures
The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success
Detailed molecular structure of silver nanocrystals determined
In an effort to understand why the Tongan Hunga volcano eruption was so explosive, internationally-recognised volcanologist Prof. Shane Cronin of the University of Auckland and associates rely on beamlines at the Australian Synchrotron to support comprehensive research on the Hunga event.
Sample environments, Data analysis, SpICE and SICS
Radiation testing of electronic components at ANTO could benefit the aviation industry, regulators and most importantly, passengers as solar radiation events increase.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.